Harrison, C. N., Schaap, N., Vannucchi, A. M., Kiladjian, J., Jourdan, E., Silver, R. T., . . . Mesa, R. A. (2021). Fedratinib Improves Myelofibrosis-related Symptoms and Health-related Quality of Life in Patients with Myelofibrosis Previously Treated with Ruxolitinib: Patient-reported Outcomes from the Phase II JAKARTA2 Trial. Hemasphere.
استشهاد بنمط شيكاغوHarrison, Claire N., et al. "Fedratinib Improves Myelofibrosis-related Symptoms and Health-related Quality of Life in Patients With Myelofibrosis Previously Treated With Ruxolitinib: Patient-reported Outcomes From the Phase II JAKARTA2 Trial." Hemasphere 2021.
MLA استشهادHarrison, Claire N., et al. "Fedratinib Improves Myelofibrosis-related Symptoms and Health-related Quality of Life in Patients With Myelofibrosis Previously Treated With Ruxolitinib: Patient-reported Outcomes From the Phase II JAKARTA2 Trial." Hemasphere 2021.